Ethypharm Announces Xavier LASSERRE as the New CCO | Leading Pharmaceutical Veteran

Denis DELVAL, President & CEO of the Ethypharm Group, announces the appointment of Xavier LASSERRE as Chief Commercial Officer (CCO), effective June 12, 2023.

Xavier LASSERRE has a strong experience and expertise in the pharmaceutical industry, particularly in the European markets, both in the retail and hospital sectors.

He holds an advanced degree in Neuroscience and is a graduate of ESCP (Paris Business School). With over 25 years of experience, he has demonstrated remarkable leadership in various roles, contributing significantly to the success and transformation of businesses under his responsibility. Xavier’s most recent position was as Head of Commercial Operations at Zentiva Group, where he was a valued member of the Executive Committee, overseeing affiliate General Managers and export activities.

Xavier joins the Executive Committee of Ethypharm and leads the company’s head of affiliates UK, China, France, Spain, Germany, and Italy. Additionally, Xavier will oversee the distribution and licenses businesses, as well as the Business Development functions.

“I’ am thrilled to join Ethypharm as the new Chief Commercial Officer. Ethypharm has a strong commitment to improving patient lives, and I am eager, with the talented team at Ethypharm, to contribute to the company’s growth and success. I look forward to leading the commercial strategy, driving market expansion, and fostering collaborations to bring our valuable treatments to more patients worldwide.” Says Xavier LASSERRE.

Denis DELVAL – CEO & President of the Group Ethypharm, expresses confidence in Xavier’s ability to drive the company’s commercial growth and stated, “We are delighted to welcome Xavier to the Ethypharm Group. His extensive experience and proven track record in the pharmaceutical industry make him an ideal fit for our organization. We are confident that Xavier’s commercial talent and expertise combined with his leadership will contribute significantly to our continued success. We are excited about this new chapter and look forward to working together towards achieving our goals and further strengthening our position in the market.”

Other Executives In the News

SourceEthypharm
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy